Some previous studies suggest the increase in TNF-α and the decrease of adiponectin, may be indicative of disease progression to NASH (Polyzos et al., 2016; Mohamed et al., 2017). Here, ADIPOQ is linked to metabolic dysfunction-associated steatohepatitis.